13 results for author:"Rodien P." in Literature citations
Results Customize
› Repeat search in UniProtKB (7)
| Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds. Tichomirowa M.A., Lee M., Barlier A., Daly A.F., Marinoni I., Jaffrain-Rea M.L., Naves L.A., Rodien P., Rohmer V., Faucz F.R. et al. Endocr. Relat. Cancer 19:233-241(2012) · Mapped (8) |
| Ovarian hyperstimulation syndrome (OHSS) due to mutations in the follicle-stimulating hormone receptor. Rodien P., Beau I., Vasseur C. Ann. Endocrinol. (Paris) 71:206-209(2010) · Mapped (5) |
| The cloned equine thyrotropin receptor is hypersensitive to human chorionic gonadotropin; identification of three residues in the extracellular domain involved in ligand specificity. Royer J., Lefevre-Minisini A., Caltabiano G., Lacombe T., Malthiery Y., Savagner F., Pardo L., Rodien P. Endocrinology 149:5088-5096(2008) · UniProtKB (1) |
| Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. Jacques C., Baris O., Prunier-Mirebeau D., Savagner F., Rodien P., Rohmer V., Franc B., Guyetant S., Malthiery Y., Reynier P. J. Clin. Endocrinol. Metab. 90:2314-2320(2005) · UniProtKB (1) |
| Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Friesema E.C.H., Grueters A., Biebermann H., Krude H., von Moers A., Reeser M., Barrett T.G., Mancilla E.E., Svensson J., Kester M.H.A. et al. |
| Modulation of ligand selectivity associated with activation of the transmembrane region of the human follitropin receptor. Montanelli L., Van Durme J.J., Smits G., Bonomi M., Rodien P., Devor E.J., Moffat-Wilson K., Pardo L., Vassart G., Costagliola S. Mol. Endocrinol. 18:2061-2073(2004) · Mapped (5) |
| A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. Vasseur C., Rodien P., Beau I., Desroches A., Gerard C., de Poncheville L., Chaplot S., Savagner F., Croue A., Mathieu E. et al. N. Engl. J. Med. 349:753-759(2003) · UniProtKB (1) |
| Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Vlaeminck-Guillem V., Ho S.C., Rodien P., Vassart G., Costagliola S. Mol. Endocrinol. 16:736-746(2002) · Mapped (6) |
| A familial case of congenital hypothyroidism caused by a homozygous mutation of the thyrotropin receptor gene. Bretones P., Duprez L., Parma J., David M., Vassart G., Rodien P. Thyroid 11:977-980(2001) · Mapped (6) |
| Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. Rodien P., Bremont C., Raffin Sanson M.-L., Parma J., van Sande J., Costagliola S., Luton J.-P., Vassart G., Duprez L. N. Engl. J. Med. 339:1823-1826(1998) · UniProtKB (1) |
| Evidences for an allelic variant of the human LC/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptors. Rodien P., Cetani F., Costagliola S., Tonacchera M., Duprez L., Minegishi T., Govaerts C., Vassart G. J. Clin. Endocrinol. Metab. 83:4431-4434(1998) · UniProtKB (1) |
| Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. Parma J., Duprez L., van Sande J., Hermans J., Rocmans P., van Vliet G., Costagliola S., Rodien P., Dumont J.E., Vassart G. J. Clin. Endocrinol. Metab. 82:2695-2701(1997) · UniProtKB (1) |
| Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. Rodien P., Mebarki F., Mowszowicz I., Chaussain J.L., Young J., Morel Y., Schaison G. J. Clin. Endocrinol. Metab. 81:2994-2998(1996) · UniProtKB (1) |